High-dose infusional doxorubicin and cyclophosphamide: A feasibility study of tandem high-dose chemotherapy cycles without stem cell support
Robert J. Morgan, James H. Doroshow, Kalyanasundaram Venkataraman, Karen Chang, James Raschko, George Somlo, Lucille Leong, Merry Tetef, Stephen Shibata, Victor Hamasaki, Kim Margolin, Stephen Forman, Steven Akman, Paul Coluzzi, Chul Ahn, Lawrence Weiss, Uday Gadgil, Jonathan Harrison
Dive into the research topics of 'High-dose infusional doxorubicin and cyclophosphamide: A feasibility study of tandem high-dose chemotherapy cycles without stem cell support'. Together they form a unique fingerprint.